Hepatotoxicity evaluation of traditional Chinese medicines using a computational molecular model

References

• Zhao P, Wang C, Liu W, et al. Acute liver failure associated with traditional Chinese medicine: report of 30 cases from seven tertiary hospitals in China. Crit Care Med. 2014;42:e296–e299.
   PubMed Web of Science ®Google Scholar
• Liu SH, Chuang WC, Lam W, et al. Safety surveillance of traditional Chinese medicine: current and future. Drug Saf. 2015;38:117–128.
   PubMed Web of Science ®Google Scholar
• Stickel F, Shouval D. Hepatotoxicity of herbal and dietary supplements: an update. Arch Toxicol. 2015;89:851–865.
   PubMed Web of Science ®Google Scholar
• Yuen MF, Tam S, Fung J, et al. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment Pharmacol Ther. 2006;24:1179–1186.
   PubMed Web of Science ®Google Scholar
• Nissan R, Poperno A, Stein GY, et al. A case of hepatotoxicity induced by adulterated “Tiger King”, a Chinese herbal medicine containing sildenafil. CDS. 2016;11:184–188.
   Google Scholar
• Teschke R, Zhang L, Long H, et al. Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases. Ann Hepatol. 2015;14:7–19.
   PubMed Web of Science ®Google Scholar
• Gibb S. Toxicity testing in the 21st century: a vision and a strategy. Reprod Toxicol. 2008;25:136–138.
   PubMedGoogle Scholar
• Przybylak KR, Cronin MT. In silico models for drug induced liver injury-current status. Expert Opin Drug Metab Toxicol. 2012;8:201–217.
   PubMed Web of Science ®Google Scholar
• Huang SH, Tung CW, Fülöp F, et al. Developing a QSAR model for hepatotoxicity screening of the active compounds in traditional Chinese medicines. Food Chem Toxicol. 2015;78:71–77.
   PubMed Web of Science ®Google Scholar
• Zhu XW, Sedykh A, Liu SS. Hybrid in silico models for drug-induced liver injury using chemical descriptors and in vitro cell-imaging information. J Appl Toxicol. 2014;34:281–288.
   PubMed Web of Science ®Google Scholar
• Chen M, Hong H, Fang H, et al. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs. Toxicol Sci. 2013;136:242–249.
   PubMed Web of Science ®Google Scholar
• Chen M, Vijay V, Shi Q, et al. FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today. 2011;16:697–703.
   PubMed Web of Science ®Google Scholar
• Foti RS, Dickmann LJ, Davis JA, et al. Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplements. Xenobiotica. 2008;38:264–280.
   PubMed Web of Science ®Google Scholar
• Lu H, Zhang L, Gu LL, et al. Oxymatrine induces liver injury through JNK signalling pathway mediated by TNF-α in vivo. Basic Clin Pharmacol Toxicol. 2016;119:405–411.
   PubMed Web of Science ®Google Scholar
• Tu M, Sun S, Wang K, et al. Organic cation transporter 1 mediates the uptake of monocrotaline and plays an important role in its hepatotoxicity. Toxicology. 2013;311:225–230.
   PubMed Web of Science ®Google Scholar
• Jin J, Sun X, Zhao Z, et al. Activation of the farnesoid X receptor attenuates triptolide-induced liver toxicity. Phytomedicine. 2015;22:894–901.
   PubMed Web of Science ®Google Scholar
• Wen B, Roongta V, Liu L, et al. Metabolic activation of the indoloquinazoline alkaloids evodiamine and rutaecarpine by human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4. Drug Metab Dispos. 2014;42:1044–1054.
   PubMed Web of Science ®Google Scholar
• Wu JL, Leung EL, Zhou H, et al. Metabolite analysis of toosendanin by an ultra-high performance liquid chromatography-quadrupole-time of flight mass spectrometry technique. Molecules. 2013;18:12144–12153.
   PubMed Web of Science ®Google Scholar
• Fu S, Korkmaz E, Braet F, et al. Influence of kavain on hepatic ultrastructure. WJG. 2008;14:541–546.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhou J, Wang S, et al. Shotgun approach based comparative proteomic analysis of levo-tetrahydropalmatine-induced apoptosis in hepatocytes. Toxicol Lett. 2010;194:8–15.
   PubMed Web of Science ®Google Scholar
• Lin G, Wang JY, Li N, et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol. 2011;54:666–673.
   PubMed Web of Science ®Google Scholar
• Anderson IB, Mullen WH, Meeker JE, et al. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med. 1996;124:726–734.
   PubMed Web of Science ®Google Scholar
• Brkanac SR, Gerić M, Gajski G, et al. Toxicity and antioxidant capacity of Frangula alnus Mill. bark and its active component emodin. Regul Toxicol Pharmacol. 2015;73:923–929.
   PubMed Web of Science ®Google Scholar
• Hong H, Xie Q, Ge W, et al. Mold(2), molecular descriptors from 2D structures for chemoinformatics and toxicoinformatics. J Chem Inf Model. 2008;48:1337–1344.
   PubMed Web of Science ®Google Scholar
• The R Project for statistical computing. [cited 2016 May 7] Available from: https://www.r-project.org.
   Google Scholar
• Polishchuk PG, Muratov EN, Artemenko AG, et al. Application of random forest approach to QSAR prediction of aquatic toxicity. J Chem Inf Model. 2009;49:2481–2488.
   PubMed Web of Science ®Google Scholar
• Dolezal R, Van Damme S, Bultinck P, et al. QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors. Eur J Med Chem. 2009;44:869–876.
   PubMed Web of Science ®Google Scholar
• Li Z, Zheng L, Shi J, et al. Toxic markers of Matrine determined using (1) H-NMR-based metabolomics in cultured cells in vitro and rats in vivo. Evid Based Complement Alternat Med. 2015;2015:598412.
   PubMed Web of Science ®Google Scholar
• Ma Y, Niu C, Wang J, et al. Diosbulbin B-induced liver injury in mice and its mechanism. Hum Exp Toxicol. 2014;33:729–736.
   PubMed Web of Science ®Google Scholar
• Li SL, Lin G, Fu PP, et al. Identification of five hepatotoxic pyrrolizidine alkaloids in a commonly used traditional Chinese medicinal herb, Herba Senecionis scandentis (Qianliguang). Rapid Commun Mass Spectrom. 2008;22:591–602.
   PubMed Web of Science ®Google Scholar
• Gao H, Li N, Wang JY, et al. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. J Dig Dis. 2012;13:33–39.
   PubMed Web of Science ®Google Scholar
• Gizatullina ZZ, Fesenko LM, Dombrovskaya NV, et al. Disturbances in oxidative phosphorylation in the liver of rats with heliotrine-induced hepatitis and restoration by phosphatidylcholine and ATP. Biomed Sci. 1991;2:460–464.
   PubMedGoogle Scholar
• Zhou SF, Xue CC, Yu XQ, et al. Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. CDM. 2007;8:526–553.
   Google Scholar
• Best DH, Butz GM, Coleman WB. Cytokine-dependent activation of small hepatocyte-like progenitor cells in retrorsine-induced rat liver injury. Exp Mol Pathol. 2010;88:7–14.
   PubMed Web of Science ®Google Scholar
• Li J, Dai CX, Sun H, et al. Protective effects and mechanisms of curcumin on podophyllotoxin toxicity in vitro and in vivo. Toxicol Appl Pharmacol. 2012;265:190–199.
   PubMed Web of Science ®Google Scholar
• Stegelmeier BL, Brown AW, Welch KD. Safety concerns of herbal products and traditional Chinese herbal medicines: dehydropyrrolizidine alkaloids and aristolochic acid. J Appl Toxicol. 2015;35:1433–1437.
   PubMed Web of Science ®Google Scholar
• Cai Q, Wei J, Zhao W, et al. Toxicity of Evodiae fructus on rat liver mitochondria: the role of oxidative stress and mitochondrial permeability transition. Molecules. 2014;19:21168–21182.
   PubMed Web of Science ®Google Scholar
• Teschke R. Traditional Chinese Medicine induced liver injury. J Clin Transl Hepatol. 2014;2:80–94.
   PubMedGoogle Scholar
• Chalasani N, Bonkovsky HL, Fontana R, United States Drug Induced Liver Injury Network, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148:1340–1352.e7.
   PubMed Web of Science ®Google Scholar
• Zhao P, Wang C, Liu W, et al. Causes and outcomes of acute liver failure in China. PLoS One. 2013;8:e80991.
   PubMed Web of Science ®Google Scholar
• Ortega-Alonso A, Stephens C, Lucena MI, et al. Case characterization, clinical features and risk factors in drug-induced liver injury. IJMS. 2016;17:pii: E714.
   Google Scholar
• Teschke R, Wolff A, Frenzel C, et al. Review article: herbal hepatotoxicity-an update on traditional Chinese medicine preparations. Aliment Pharmacol Ther. 2014;40:32–50.
   PubMed Web of Science ®Google Scholar
• Klein SD, Becker S, Wolf U. Occurrence of chai hu (Bupleuri radix) in prescriptions of Chinese herbal medicine in Switzerland. Forsch Komplementmed. 2012;19:242–246.
   PubMedGoogle Scholar
• Teo DC, Ng PS, Tan SH, et al. Drug-induced liver injury associated with Complementary and Alternative Medicine: a review of adverse event reports in an Asian community from 2009 to 2014. BMC Complement Altern Med. 2016;16:192.
   PubMed Web of Science ®Google Scholar
• Lee CH, Wang JD, Chen PC. Risk of liver injury associated with Chinese herbal products containing Radix bupleuri in 639,779 patients with hepatitis B virus infection. PLoS One. 2011;6:e16064.
   PubMed Web of Science ®Google Scholar
• Seeff LB, Bonkovsky HL, Navarro VJ, et al. Herbal products and the liver: a review of adverse effects and mechanisms. Gastroenterology. 2015;148:517–532.e3.
   PubMed Web of Science ®Google Scholar
• Calitz C, du Plessis L, Gouws C, et al. Herbal hepatotoxicity: current status, examples, and challenges. Expert Opin Drug Metab Toxicol. 2015;11:1551–1565.
   PubMed Web of Science ®Google Scholar
• Teschke R, Eickhoff A. Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Front Pharmacol. 2015;6:72.
   PubMed Web of Science ®Google Scholar
• Hillman L, Gottfried M, Whitsett M, et al. Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury. Am J Gastroenterol. 2016;111:958–965.
   PubMed Web of Science ®Google Scholar